Skip to content
Research Article Open access CC BY 4.0

Supraventricular Tachy-arrhythmia Revealing an Arrhythmogenic Right Ventricle Cardiomyopathy in An Adolescent: Case Report

B. Mohamed Ghoulame, H. Siyam, P. M. Mulendele, S.M. Obeidat, M. BOUZIANE, M. HABOUB, S. AROUS, G. Bennouna, A. DRIGHIL, R. HABBAL

Cardiology and Angiology: An International Journal · pp. 108–114 · Published 16 May 2024

10.9734/ca/2024/v13i2411

Abstract

Arrhythmogenic right ventricular cardiomyopathy is a genetic disease that affects young people. As its name indicates, it carries a risk of ventricular rhythm disturbances and sudden death, particularly during sporting efforts emphasizing the need for early diagnosis of the disease. The most frequently observed symptoms are palpitations, syncope, clinical signs of right heart failure and cardiac arrest. These clinical manifestations, as well as the progression and prognosis of the disease have been well studied and described in the literature in adult population unlike in children where it has not been well elucidated. Its diagnosis is based on the morphological characteristics of the right ventricle during cardiac ultrasound and especially on cardiac MRI. The extent of morphological abnormalities and the frequency of occurrence of rhythm disorders make it possible to stratify the disease risk. High-risk patients should benefit from implantable cardioverter defibrillator implantation. Treatment is based on moderate physical exercise, beta blockers medical therapy and an implantable cardioverter defibrillator in certain cases. We report a case of a 15-year-old child, with a history of first-degree consanguinity and undocumented heart disease in the father who consulted for chest pain over 8 days. The clinical presentation, electrical signs, cardiac ultrasound and imaging made it possible to make the diagnosis of ARVC.

Arrhythmogenic right ventricle cardiomyopathy task force criteria cMRI ICD

References (11)

  1. 1 Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. [DOI]
  2. 2 Trends in Sudden Cardiovascular Death in Young Competitive Athletes After Implementation of a Preparticipation Screening Program [DOI]
  3. 3 Arrhythmogenic Right Ventricular Dysplasia [DOI]
  4. 4 Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice [DOI]
  5. 5 Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratification [DOI]
  6. 6 Arrhythmogenic Right Ventricular Dysplasia [DOI]
  7. 7 Does sports activity enhance the risk of sudden death in adolescents and young adults? [DOI]
  8. 8 Importance of CMR Within the Task Force Criteria for the Diagnosis of ARVC in Children and Adolescents [DOI]
  9. 9 Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia [DOI]
  10. 10 Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Without an Implantable Cardioverter-Defibrillator [DOI]
  11. 11 Management of arrhythmogenic right ventricular cardiomyopathy [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

82

Page views

0

PDF downloads

63

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.